Deborah M. Messemer, Director at Allogene Therapeutics, Inc. (ALLO), sold 9,136 shares at $2.18 ($20K) on 2024-12-09, disclosed to the SEC on 2024-12-10.
Open-market sale of $20k ALLO by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| PYPL | SELL | 2025-06-06 | $277K | — | Filing → |
| ALLO | SELL | 2025-02-20 | $32K | — | Filing → |
| TPG | SELL | 2025-01-15 | $210K | — | Filing → |